GLP-1 therapies, or glucagon-like peptide-1 receptor agonists , represent a substantial development in how we treat type 2 diabetes . These prescription drugs work by stimulating the body’s own GLP-1 https://bacteriastatic-water754425.gynoblog.com/profile